Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson’s Disease: Beyond the Primary Mechanism of Action

Symptoms of cognitive impairment are rather common since the early stage of Parkinson’s disease (PD); they aggravate with disease progression and may lead to dementia in a significant proportion of cases. Worsening of cognitive symptoms in PD patients depends on the progression of subcortical dopami...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinaldi, Domiziana, Alborghetti, Marika, Bianchini, Edoardo, Sforza, Michela, Galli, Silvia, Pontieri, Francesco E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286595/
https://www.ncbi.nlm.nih.gov/pubmed/36065929
http://dx.doi.org/10.2174/1570159X20666220905102144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286595/
https://www.ncbi.nlm.nih.gov/pubmed/36065929
http://dx.doi.org/10.2174/1570159X20666220905102144

Ejemplares similares